Skip to main content
. 2019 Oct 23;9:15234. doi: 10.1038/s41598-019-51675-y

Table 4.

Overall survival analyses according to preoperative PDW in 495 patients with ESCC.

Variables Univariate Multivariate
HR 95% CI P value HR 95% CI P value
PDW (≥13.4 vs. <13.4) 5.111 3.101–8.425 <0.001 1.194 1.120–1.273 <0.001
Sex (male vs.female) 1.676 0.845–3.326 0.139
Age (>60 vs. ≤60) 1.238 0.833–1.838 0.291
Depth of tumor
T1a–1b 0.296 0.093–0.937 0.038 0.447 0.116–1.722 0.242
T2 0.607 0.355–1.038 0.607 0.435 0.135–1.399 0.162
T3 1.000 1.000
Lymph node metastasis
N0 0.112 0.056–0.222 <0.001 0.073 0.015–0.363 0.001
N1 0.308 0.164–0.576 <0.001 0.331 0.168–0.650 0.001
N2 0.432 0.219–0.855 0.016 0.486 0.240–0.985 0.045
N3 1.000 1.000
Pathological stage
1a–1b 0.194 0.084–0.447 <0.001 2.384 0.184–30.799 0.506
2a–2b 0.395 0.251–0.623 <0.001 1.556 0.386–6.283 0.534
3a–3c 1.000 1.000
Vessel invasive (absence vs. presence) 1.793 1.197–2.686 0.005 1.098 0.704–1.713 0.681
Nerve infiltration (absence vs. presence) 1.990 1.343–2.948 0.001 1.855 1.214–2.836 0.004
Treatment regimen
S 1.425 0.656–3.099 0.371
S plus postoperative C 1.430 0.611–3.348 0.410
S plus postoperative CRT 1.000
Hospital time (days) (>14 vs. ≤14) 1.811 1.169–2.803 0.008 1.828 1.159–2.881 0.009
Platelet 0.996 0.992–0.999 0.018 1.000 0.996–1.004 0.904
Albumin 0.931 0.884–0.981 0.007 0.947 0.892–1.006 0.076
RDW 1.258 1.016–1.557 0.035 1.072 0.838–1.370 0.579
Aspartate transaminase 0.995 0.972–1.019 0.709
Fibrinogen 1.137 0.909–1.422 0.262
Hemoglobin 0.831 0.729–0.948 0.006 0.853 0.726–1.002 0.053

Abbreviations: S, surgery; C, chemotherapy; CRT, chemoradiotherapy; PDW, platelet distribution width; RDW, red cell distribution width.